Understanding psychiatric disorders in children after serious suicide attempts

Associated Psychiatric Disorders in Children Hospitalized for a Serious Suicide Attempt

Observational Assistance Publique - Hôpitaux de Paris · NCT05450354

This study looks at the mental health issues in children aged 9 to 15 who have been hospitalized after serious suicide attempts to better understand their needs and improve support for them.

Quick facts

Study typeObservational
Enrollment200 (estimated)
Ages9 Years and up
SexAll
SponsorAssistance Publique - Hôpitaux de Paris Academic / other
Locations1 site (Paris)
Trial IDNCT05450354 on ClinicalTrials.gov

What this trial studies

This observational study aims to explore the psychiatric disorders associated with children hospitalized for serious suicide attempts. It focuses on children aged 9 to 15 who have experienced a serious suicide attempt, defined by specific hospitalization criteria. The study will utilize questionnaires to gather data on the psychological and developmental characteristics of these children, as well as those of control patients who have made non-serious attempts. The goal is to better characterize the psychiatric profiles of these children to inform future interventions and support.

Who should consider this trial

Good fit: Ideal candidates for this study are children aged 9 to 15 who have been hospitalized for a serious suicide attempt.

Not a fit: Patients with intellectual disabilities or those who do not meet the hospitalization criteria for serious suicide attempts may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and treatment of psychiatric disorders in children at risk of suicide.

How similar studies have performed: While there have been studies on suicide attempts in children, this specific focus on serious attempts and their psychiatric correlates is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients:

  * Between the ages of 9 and 15 inclusive at the time of hospitalization at the Necker Enfants Malades Hospital following a serious suicide attempt that took place after January 1, 2016.
  * Serious suicide attempt whose criteria are: hospitalization for more than 24 hours and one of the following criteria: care in a specialized service, surgery under general anesthesia, hospitalization in intensive care or continuous care or resuscitation unit, attempted suicide by methods involving a high risk of mortality: precipitation, hanging, firearm…
  * Control patients aged 9 to 15 years old hospitalized at the Necker-Enfants Malades hospital at time of the study for a non-serious suicide attempt.
  * Without intellectual disability (IQ\>70).
* Parents:

  \- At least one of the parents of a patient meeting the inclusion criteria.
* All subjects (parent(s) and minor or adult children) informed and not objecting to participation in the study. Holders of parental authority of minor patients informed and not opposing the participation of their child in the study.

Exclusion Criteria:

* Insufficient command of French to answer the questionnaires.
* Incomplete file of patients whose hospitalization is no longer in progress.
* Medical impossibility to pass the questionnaires.

Where this trial is running

Paris

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Serious Suicide AttemptSerious suicide attempt in childrenNeurodevelopmentPsycho-emotional developmentpsychopathological characteristicsAttachment disordersDisorganized attachment
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.